Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Core EBITDA Growth

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 45.59-9.0232.75-9.8316.51

What is the latest Core EBITDA Growth ratio of BLISS GVS PHARMA ?

The latest Core EBITDA Growth ratio of BLISS GVS PHARMA is 45.59 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202645.59
Mar2025-9.02
Mar202432.75
Mar2023-9.83
Mar202216.51

How is Core EBITDA Growth of BLISS GVS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 45.59
Positive
Mar2025 -9.02
Negative
Mar2024 32.75
Positive
Mar2023 -9.83
Negative
Mar2022 16.51 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Core EBITDA Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹6,851.6 Cr -2.4% -11.1% 343% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-2.4%

-11.1%

343%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses